EFFECTS OF COMT INHIBITORS ON STRIATAL DOPAMINE METABOLISM - A MICRODIALYSIS STUDY

被引:80
作者
KAAKKOLA, S [1 ]
WURTMAN, RJ [1 ]
机构
[1] MIT, DEPT BRAIN & COGNIT SCI, CAMBRIDGE, MA 02139 USA
关键词
CATECHOL-O-METHYLTRANSFERASE INHIBITOR; CLORGYLINE; DEPRENYL; INVIVO MICRODIALYSIS; DOPAMINE; NOMIFENSINE; OR-611; RO; 40-7592; STRIATUM;
D O I
10.1016/0006-8993(92)91003-W
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In vivo microdialysis was used to examine the effect of two new catechol-O-methyltransferase (COMT) inhibitors, Ro 40-7592 and OR-611, on extracellular levels of dopamine, dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and 5-hydroxyindoleacetic acid (5-HIAA) in rat striatum. The interactions of the COMT inhibitors with nomifensine, clorgyline and deprenyl were also studied. Ro 40-7592 (3-30 mg/kg, i.p.) decreased dose-dependently the efflux of HVA, increased that of DOPAC, and tended to increase that of dopamine. Higher doses of OR-611 (30-100 mg/kg, i.p.) also decreased the dialysate level of HVA, increased that of DOPAC, and tended to increase that of dopamine. Ro 40-7592 was about ten-fold as potent as OR-611. Neither of the COMT inhibitors changed dialysate levels of 5-HIAA. An OR-611 dose of 10 mg/kg i.p. had no significant effect, in contrast to Ro 40-7592, on any of the parameters studied; this dose was thus used to differentiate between the effects of central and peripheral COMT inhibition. Both nomifensine (15 mg/kg, i.p.) and clorgyline (4 mg/kg, i.p.) alone elevated extracellular dopamine levels, and lowered those of DOPAC and HVA, though there were quantitative and temporal differences between the drugs. L-Deprenyl (1 mg/kg, i.p.) alone had no significant effect on any of the compounds measured. Ro 40-7592 (10 mg/kg, i.p.) potentiated the effect of nomifensine on dopamine efflux, and it tended to increase clorgyline-induced dopamine efflux. DOPAC levels in dialysates were significantly increased by combinations of Ro 40-7592 and nomifensine or clorgyline, whereas HVA levels remained about as low as they were after Ro 40-7592 alone. Ro 40-7592 had no significant interactions with L-deprenyl. OR-611 (10 mg/kg, i.p.) did not modify the effects on dopamine metabolism of nomifensine, clorgyline or L-deprenyl. These data show that Ro 40-7592 is a potent centrally active COMT inhibitor, whereas OR-611 is principally a peripherally active inhibitor. Use of drugs which inhibit brain COMT can considerable modify dopamine metabolism. COMT inhibitors may be of clinical significance in treating Parkinson's disease.
引用
收藏
页码:241 / 249
页数:9
相关论文
共 54 条
[41]   EFFECTS OF INTRASTRIATAL KAINIC ACID INJECTION ON [H-3]DOPAMINE METABOLISM IN RAT STRIATAL SLICES - EVIDENCE FOR POSTSYNAPTIC GLIAL-CELL METABOLISM BY BOTH THE TYPE-A AND TYPE-B FORMS OF MONOAMINE-OXIDASE [J].
SCHOEPP, DD ;
AZZARO, AJ .
JOURNAL OF NEUROCHEMISTRY, 1983, 40 (05) :1340-1348
[42]   PARAVENTRICULAR NUCLEUS - A SITE FOR THE INTEGRATION OF NEUROENDOCRINE AND AUTONOMIC MECHANISMS [J].
SWANSON, LW ;
SAWCHENKO, PE .
NEUROENDOCRINOLOGY, 1980, 31 (06) :410-417
[43]  
TORNWALL M, 1991, PHARMACOL TOXICOL, V69, P64
[44]  
TRENDELENBURG U, 1990, J NEUR TR S, P3
[45]   PREFERENTIAL DEAMINATION OF DOPAMINE BY AN A-TYPE MONOAMINE-OXIDASE IN RAT-BRAIN [J].
WALDMEIER, PC ;
DELINISTULA, A ;
MAITRE, L .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1976, 292 (01) :9-14
[46]  
WALDMEIER PC, 1987, J NEURAL TRANSM, P55
[47]   SEQUENCE AND SIGNIFICANCE OF DOPAMINE METABOLISM IN THE RAT-BRAIN [J].
WESTERINK, BHC .
NEUROCHEMISTRY INTERNATIONAL, 1985, 7 (02) :221-227
[48]   BIOCHEMISTRY AND GENETICS OF MONOAMINE-OXIDASE [J].
WEYLER, W ;
HSU, YPP ;
BREAKEFIELD, XO .
PHARMACOLOGY & THERAPEUTICS, 1990, 47 (03) :391-417
[49]   INTRACEREBRAL DIALYSIS - DIRECT EVIDENCE FOR THE UTILITY OF 3-MT MEASUREMENTS AS AN INDEX OF DOPAMINE RELEASE [J].
WOOD, PL ;
KIM, HS ;
MARIEN, MR .
LIFE SCIENCES, 1987, 41 (01) :1-5
[50]   INVIVO MEASUREMENT OF DOPAMINE AND ITS METABOLITES BY INTRACEREBRAL DIALYSIS - CHANGES AFTER D-AMPHETAMINE [J].
ZETTERSTROM, T ;
SHARP, T ;
MARSDEN, CA ;
UNGERSTEDT, U .
JOURNAL OF NEUROCHEMISTRY, 1983, 41 (06) :1769-1773